Saturday, February 7, 2026

‘More of an Instinct’: Trump Explains How He’ll Decide Which Companies Get Tariff Exemptions

President Donald Trump revealed Wednesday he may grant exemptions to certain companies hurt by his sweeping tariffs based primarily on his “instinct” rather than established economic analysis.

“You almost can’t take a pencil to paper. It’s really more of an instinct than anything else,” Trump told reporters during a press conference with Treasury Secretary Scott Bessent. “Some companies, through no fault of their own, they happen to be in an industry that is more affected by these things than others.”

The vague process, without established guidelines or oversight, creates a situation where companies may need to appeal directly to the administration for relief. Trump’s statement that “you have to be able to show a little flexibility, and I’m able to do that” suggests a personalized approach to exemptions that could advantage businesses with stronger connections to the White House.

The administration has already carved out exemptions for approximately $644 billion in imports following Trump’s “Liberation Day” tariff announcements, which imposed a 10% universal tariff on imported goods plus higher “reciprocal” tariffs targeting China and European Union countries. 

The Wall Street Journal reports $185 billion of these exemptions benefit goods from Canada and Mexico, though these nations face other trade restrictions.

Trump’s approach to trade policy has introduced significant uncertainty for businesses. His metaphorical explanation about needing to go “under the wall, around the wall or over the wall” when obstacles appear did little to clarify his decision-making process, instead highlighting the unpredictable nature of the exemption system.

Pharmaceutical companies, temporarily exempted while undergoing a Section 232 investigation, may soon face what Trump described as “a major tariff” despite the ongoing review. At a National Republican Congressional Committee dinner Tuesday night, Trump indicated pharmaceutical tariffs would be announced “very soon,” suggesting the investigation’s outcome may already be predetermined.

Related: Kimbal, Elon Musk’s Brother, Calls Out Trump For “Permanent Tax” On US Consumer


Information for this story was found via the sources and companies mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver Is a Wild Animal, Gold Heads for $6,000 in 2026 | Craig Hemke

Is This the End of the Gold and Silver Rally? | Peter Grandich

Why Gold And Silver Stay High Even After Rate Cuts | Todd Bubba Horwitz

Recommended

TomaGold Confirms Presence Of Berrigan Deep Zone Following Geophysics

Antimony Resources Reports Massive Stibnite Mineralization Over 25 Metres At Marcus (West) Zone

Related News

Mexican Tequila Industry Faces Glut, Trade Threats as Demand Slows

Mexico’s tequila industry confronts mounting inventories and potential US tariffs as demand cools following years...

Wednesday, January 1, 2025, 07:47:00 AM

Trump’s Turbulence Pushes Global Funds Away From US Investment

Signs are emerging that global pension funds are losing confidence in the US, with some...

Tuesday, April 15, 2025, 09:47:00 AM

Are Russia and Iran Using Social Media Bots to Divide Trump’s MAGA Base?

Social media bots are pretending to be die-hard Trump supporters while secretly trying to tear...

Saturday, June 21, 2025, 11:31:00 AM

Three Canadian Premiers Unite on Energy Infrastructure to Counter Trump Tariffs

The premiers of Ontario, Alberta and Saskatchewan signed a comprehensive agreement Tuesday to build new...

Thursday, July 24, 2025, 03:47:00 PM

Trump to Canada: Join US as 51st State or Face Tariffs

President Donald Trump has intensified his push to make Canada the 51st state, moving beyond...

Friday, January 24, 2025, 03:43:00 PM